Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Bladder Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Bladder Cancer
    TopAbstracts in Bladder Cancer 10/21/2009 - (DGNews)
    TopAbstracts in Bladder Cancer 08/26/2009 - (DGNews)
    TopAbstracts in Bladder Cancer 07/29/2009 - (DGNews)
    Most High-Risk Patients May Not Benefit From Bladder-Cancer Screenings - (DGNews)
    TopAbstracts in Bladder Cancer 07/01/2009 - (DGNews)

    News archive

     Recent webcasts/CME

      Webcasts/CME archive

       Recent cases - Bladder Cancer
        Plasmacytoid Urothelial Carcinoma of the Bladder: A Case Report
        Peritoneal Tuberculosis and Granulomatous Hepatitis Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin
        Primary Osteosarcoma of the Urinary Bladder Following Cyclophosphamide Therapy for Systemic Lupus Erythematosus: A Case Report
        Invasive Carcinoma of Urinary Bladder in a Patient with A Spinal Cord Injury with Non-Functioning Brindley Sacral Anterior Root Stimulator: A Case Report
        Adenocarcinoma of the Bladder Following Nephrogenic Adenoma: A Case Report

        Cases archive
          




        my personal edition > bladder cancer > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Radical Radiotherapy And Cystectomy For Bladder Cancer Have Similar Morbidity, Mortality

        A DGReview of :"A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire."
        European Urology

        03/12/2003
        By Alison Palkhivala


        Radical radiotherapy and cystectomy for treatment of invasive bladder cancer appear to yield similar morbidity and mortality rates, according to a retrospective study.

        R. Chahal and colleagues from the department of urology, Orchard House, Pinderfields and Pontefract NHS Trust, Wakefield, England, investigated the morbidity and mortality associated with radical cystectomy and radical radiotherapy for the treatment of invasive carcinoma of the bladder.

        They identified 398 patients with invasive carcinoma of the bladder who underwent treatment in the Yorkshire region of England between 1993 and 1996. Among these patients, 302 received radical radiotherapy and 96 received radical cystectomy.

        A retrospective review of patient medical data revealed that the patients who underwent radiotherapy were significantly older than those who underwent cystectomy (71 versus 66 years of age). However, there was no difference between the two groups with respect to the distribution of American Society of Anaesthesiologists (ASA) tumour grades. Both groups of patients experienced significant delays between the time of diagnosis and treatment: 4.3 weeks in the cystectomy group and 9 weeks in the radiotherapy group.

        The 30-day treatment-associated mortality rate was 3.1% for cystectomy and 8.3% for radiotherapy. The three-month treatment-associated mortality rate was 0.3% for cystectomy and 1.65% for radiotherapy. Among the 302 patients who received radiotherapy, 57 or 18.8% subsequently underwent salvage cystectomy. Among these patients, 30-day mortality after salvage cystectomy was 8.8% and three-month mortality after salvage cystectomy was 15.7%.

        Most cases of early morbidity following primary and salvage cystectomy were due to gastrointestinal complications. Bowel complications, both leakage and obstruction were the major cause of death following salvage cystectomy. Urinary leakage occurred in 4% of cystectomy cases, both primary and salvage. During the follow-up period after cystectomy, most complications were due to recurrent pyelonephritis and intestinal obstruction.

        Following radical radiotherapy, most complications were due to bladder and gastrointestinal complications, primarily irritative bladder and rectum. Severe bladder problems resulting in a non-functional bladder occurred in 6.3% of patients, and 2.3% of patients required surgery to relieve bowel obstruction.

        Overall, 43.6% of patients who underwent radiotherapy experienced recurrences in the bladder. Of these, 40% had stage T2 disease or greater.

        Five-year survival was 37.4% among patients who underwent radiotherapy and 36.5% among patients who underwent cystectomy. The difference in these rates was not statistically significant. Multivariate analysis revealed that the only independent predictors of five-year survival were tumour stage, ASA grade and sex.

        Based on these findings, the investigators concluded that radical radiotherapy and radical cystectomy for the treatment of invasive bladder cancer yield similar five-year survival rates. Both treatments are associated with significant mortality and morbidity rates, and gastrointestinal complications accounted for most complications. Treatment-associated mortality was two- to threefold higher at three months than it was at 30 days, which emphasises the importance of the later period as a true indicator of the risk of cystectomy. Only clinical T stage, sex and ASA grade were independent predictors of five-year survival.
        Eur Urol 2003 Mar;43:3:246-57. "A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send